Glooko, Inc. Company Profile

07:43 EST 16th December 2018 | BioPortfolio

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-management mobile app automatically syncs data from devices including blood glucose meters, insulin pumps, CGMs, smart insulin pens and many fitness and activity trackers. The broad variety of data sources provides timely and verified information, enabling PWDs and care teams to correlate insights with diet, exercise, medication and other data. We provide care teams with an easy clinic data upload solution and a population health app so they can support PWDs during and in-between office visits. Trusted by the world’s leaders in diabetes care, we are used by 7,000 providers and over 1.5 million PWDs across 23 countries in 15 languages. Learn more by visiting

News Articles [8 Associated News Articles listed on BioPortfolio]

Glooko Unveils Web-based Diabetes Analytics Platform

Diabetes management provider Glooko has unveiled new version of the Glooko Web Application (Population Tracker) that includes streamlined navigation and a large array of diabetes analytics, charts and...

Glooko to demonstrate new version of diabetes management mobile application at ADA meeting

Glooko, the leader in diabetes data management, today announced participation in the 78th Annual American Diabetes Association meeting taking place this weekend in Orlando, Fla.

Glooko Introduces New Web Analytics Platform That Includes the Most Powerful Capabilities From Diasend

New version features support for the Ambulatory Glucose Profile (AGP), new dashboards and reports Glooko, the leader in diabetes data management, today announced the de...

Glooko Releases New Version of Mobile App, Presents Usability Outcomes From Mobile Insulin Dosing System (MIDS) Study

Insights to be shared this weekend at the 78th Scientific Sessions of American Diabetes Association Glooko, the leader in diabetes data management, today anno...

Novo Nordisk to launch connected insulin pens

Also partners with Dexcom, Glooko and Roche on digital platforms

Senseonics & Glooko Announce Partnership on Integrated Diabetes Management

World’s first long-term CGM system to be integrated with world’s leading diabetes management platform Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology...

Senseonics enters systems integration deal with Glooko

A partnership deal has been reached by Senseonics to integrate its Eversense continuous glucose monitoring system with the di -More- 

Insulet Extends Partnership with Glooko in Europe to Optimise Diabetes Data Management

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipo...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Glooko Enabled Remote Monitoring for Insulin-treated Patients With Type 2 Diabetes

The purpose of this study is to compare HbA1c of insulin-treated subjects with type 2 diabetes managed via usual care alone and usual care augmented with remote monitoring using Glooko

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

This is a two-armed mixed methods study of participants (n=30) diagnosed with type 2 diabetes who use a blood glucose meter as part of their treatment regimen. Participants will have eithe...

Insulin Degludec Titration Using Mobile Insulin Dosing System

This is an open label randomized, controlled, parallel intervention study. Group 1 will receive usual care for insulin degludec titration using the STEP WISE degludec titration algorithm G...

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, ca...

Effects of a Remote Patient Monitoring Protocol on Glycemic Control in Adolescents With Type 1 Diabetes

This study will use a randomized, crossover design. Children aged 13-18 years who have been diagnosed with Type 1 diabetes for at least 1 year and with at least 2 Hemoglobin A1c values ≥...

Companies [2 Associated Companies listed on BioPortfolio]


Glooko is the leading diabetes data management platform and is trusted by the world’s leaders in diabetes care. Over 6,000 providers in 27 countries use Glooko’s FDA-cle...

Glooko, Inc.

Glooko provides insights into diabetes by enabling both people with diabetes (PWDs) and their care teams with technology to understand and manage diabetes care. Our self-managemen...

More Information about "Glooko, Inc." on BioPortfolio

We have published hundreds of Glooko, Inc. news stories on BioPortfolio along with dozens of Glooko, Inc. Clinical Trials and PubMed Articles about Glooko, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glooko, Inc. Companies in our database. You can also find out about relevant Glooko, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Corporate Database Quicklinks

Searches Linking to this Company Record